Geospace Technologies Corporation (GEOS) Drops 9.82% on February 16

Equities Staff |

Geospace Technologies Corporation (GEOS) was one of the Russell 2000's biggest losers for Tuesday February 16 as the stock slid 9.82% to $9.27, a loss of $-1.0099 per share. Starting at an opening price of $10.51 a share, the stock traded between $8.90 and $10.90 over the course of the trading day. Volume was 172,433 shares over 1,334 trades, against an average daily volume of 222,708 shares and a total float of 13.33 million.

The losses send Geospace Technologies Corporation down to a market cap of $123.55 million. In the last year, Geospace Technologies Corporation has traded between $26.75 and $7.62, and its 50-day SMA is currently $11.02 and 200-day SMA is $15.96.

Geospace Technologies Corp is engaged in designing and manufacturing of instruments and equipment used in the oil and gas industry for acquiring seismic data to locate, characterize and monitor hydrocarbon producing reservoirs.

Geospace Technologies Corporation is based out of Houston, TX and has some 978 employees. Its CEO is Walter R. Wheeler.

For a complete fundamental analysis analysis of Geospace Technologies Corporation, check out Equities.com’s Stock Valuation Analysis report for GEOS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…